Brandywine Oak Private Wealth LLC Has $1.31 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Brandywine Oak Private Wealth LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,482 shares of the healthcare conglomerate’s stock after selling 39 shares during the quarter. Brandywine Oak Private Wealth LLC’s holdings in UnitedHealth Group were worth $1,307,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares in the last quarter. Northern Trust Corp boosted its stake in UnitedHealth Group by 3.6% during the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after acquiring an additional 341,749 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.2% during the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after acquiring an additional 180,331 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 0.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock valued at $2,937,976,000 after buying an additional 27,127 shares in the last quarter. Finally, Sanders Capital LLC lifted its stake in shares of UnitedHealth Group by 6.5% in the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock valued at $2,902,829,000 after buying an additional 352,710 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Truist Financial reiterated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, TD Cowen lowered their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Performance

Shares of UNH traded up $2.53 during trading hours on Wednesday, hitting $486.23. The company’s stock had a trading volume of 677,635 shares, compared to its average volume of 4,419,183. The company has a market cap of $447.37 billion, a price-to-earnings ratio of 29.74, a PEG ratio of 1.42 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The business has a 50 day simple moving average of $484.44 and a two-hundred day simple moving average of $513.42. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the company earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.